{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37414281",
  "DateCompleted": {
    "Year": "2023",
    "Month": "11",
    "Day": "02"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "07",
        "Day": "05"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.japh.2023.06.025",
      "S1544-3191(23)00238-8"
    ],
    "Journal": {
      "ISSN": "1544-3450",
      "JournalIssue": {
        "Volume": "63",
        "Issue": "5",
        "PubDate": {
          "Year": "2023",
          "Season": "Sep-Oct"
        }
      },
      "Title": "Journal of the American Pharmacists Association : JAPhA",
      "ISOAbbreviation": "J Am Pharm Assoc (2003)"
    },
    "ArticleTitle": "Revisiting the continuum of pharmacist prescriptive authority.",
    "Pagination": {
      "StartPage": "1508",
      "EndPage": "1514",
      "MedlinePgn": "1508-1514"
    },
    "Abstract": {
      "AbstractText": [
        "Pharmacists in all states have prescriptive authority in some form. We identify two broad categories of pharmacist prescribing: dependent and independent. There are gradients within these broad categories that allow us to chart pharmacist prescribing on a continuum from most restrictive to least restrictive. Independent prescribing has seen the most innovation in recent years at the state level, with at least three states adopting a \"standard of care\" prescribing framework that allows pharmacists to exercise broad prescriptive authority including for conditions that require a diagnosis. Each of the approaches to pharmacist prescriptive authority have perceived advantages and disadvantages as it relates to improving patient care."
      ],
      "CopyrightInformation": "Copyright \u00a9 2023 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Adams",
        "ForeName": "Alex J",
        "Initials": "AJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Weaver",
        "ForeName": "Krystalyn K",
        "Initials": "KK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Adams",
        "ForeName": "Jennifer Athay",
        "Initials": "JA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Am Pharm Assoc (2003)",
    "NlmUniqueID": "101176252",
    "ISSNLinking": "1086-5802"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Prescriptions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pharmacists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Professional Role"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Patient Care"
    }
  ]
}